Table 1

Overview of the included studies

Author
(year), country		PROMCountryLanguage(s) of PROMStudy designTarget populationSample sizeMeasurement domainNo of itemsTotal score range
Avis23 2005QLACS financial problems domainUSAEnglishDevelopment and validation studyAge: 71.4±11.5 years
Male: 42%
Cancer type: Breast, bladder, head and neck, gynecologic, prostate, colorectal cancer		242One domain regarding financial problems44–28
Chan24 2021COST-v2, Traditional Chinese versionHong KongTraditional ChineseValidation studyAge: 59.9±11.1 years
Male: 35.3%
Cancer type: Breast, gynaecological, head and neck, gastric and colorectal, genitourinary, lung, haematological, skin, bone and soft tissue, brain and central nervous system cancer and others		640No subdomain120–44
Dar25 2021COST-v1, India versionIndiaHindi or EnglishValidation studyAge: 49.5±16.8 years
Male: 82.8%
Cancer type: Tongue, gingival buccal sulcus, buccal mucosa, supraglottic larynx, hypopharynx, parotid and others		29No subdomain110–44
Dar25 2021SFDQIndiaIndian or EnglishDevelopment and validation studyAge: 18%–59 68.3%; ≥60 310.7%
Male: 85.9%
Cancer type: head and neck cancer		142Five domains: financial resources; financial spending; psychosocial affect; coping care and coping lifestyles; support seeking140–28
de Alcantara Nogueira32 2020COST-v1, Brazilian versionBrazilBrazilian PortugueseValidation studyMean age: 56 years
Male: 40.5%
Cancer type: Not specific		126No subdomain110–44
De Souza12 2014
De Souza27 2017		COST-v1USAEnglishDevelopment study and validation studyAge: 58.4±11.5 years
Male: 41.6%
Cancer type: Not specified (diagnosis of AJCC stage IV cancer)		233No subdomain110–44
Durber28 2021COST-v1AustraliaEnglishValidation studyAge: ≤50 years 23%; 51–64 years 30%; ≥65 years 48%
Male: 46%
Cancer type: Thoracic, breast, sarcoma, skin, central nervous system, gynaecological, head and neck, colorectal, upper gastrointestinal, urological and miscellaneous cancer		257No subdomain110–44
Harley29 2019CCEQ financial advice domainUKEnglishDevelopment and validation studyPilot study:
Age: 65 (41-90) yrs
Male: 48.5%
Cancer type: Breast, colorectal/gastrointestinal, gynaecological, prostate and renal cancer
Final study:
Age: 67 (41–88) yrs
Male: 50.0%
Cancer type: Breast, colorectal/gastrointestinal, gynaecological, prostate and renal cancer		103 for pilot study
313 for final study		One domain regarding financial advice55–25
Head14 2008SWBSUSAEnglishDevelopment and validation studyAge: 59.6±12.7 years
Male: 35.7%
Cancer type: Breast, melanoma, head and neck, prostate, rectum/anus, colon, endometrium, lung/tracheal/bronchus and non-Hodgkin’s lymphoma		266Two domains: material and social capital.170–68
Hueniken31 2020FITCanadaEnglishDevelopment and validation studyAge: 61.6 (25.5–88.5) yrs
Male: 77.2%
Cancer type: Oropharynx, oral cavity, larynx, nasopharynx, hypopharynx cancers and others		430No subdomain90–100
Ripamonti33 2020COST-v2, Italian versionItalyItalianValidation studyAge: 61.5±12.7 years
Male: 52.5%
Cancer type: Breast, lung, colon, gastric, hepatocellular, endometrial, prostate, sarcoma, bladder, head and neck, Hodgkin lymphoma, non-Hodgkin's lymphoma, leukaemia, myeloma and others		118No subdomain110–44
Riva42 2021PROFFITItalyItalian or EnglishDevelopment and validation studyAge: 29–82 years
Male: 41.3%
Cancer type: breast, lower gastrointestinal tract, genitourinary, thoracic, upper gastrointestinal tract and others		184No subdomainSeven outcome items and eight determinant items0–100
Sharif34 2020COST-v2, Persian versionIranPersianValidation studyAge: 50.0±14.3 years
Male: 51.0%
Cancer type: Not specific		398No subdomain110–44
Shilling35 2018PRRS financial well-being domainUKEnglishDevelopment and validation studyAge: ≤50 years 25%; 51–65 years 41%; ≥66 years 34%
Male: 23%
Cancer type: breast, gynaecological, lung and melanoma cancers		135One domain regarding financial well-being60–24
Tremblay36 2020P-SAFE, French VersionCanadaFrenchCross-adaption studyAge: 50–59 years 57%; 60–69 years 29%; ≥70 years 34%
Male: 14%
Cancer type: colorectal, lung, breast and prostate cancer.		7NR23NR
Veenstra37 2014PFBUSAEnglishValidation studyAge: <50 years 17%; 50–64 years 37%; 65–74 years 23%; >75 years 24%
Male: 53%
Cancer type: Stage III colorectal cancer		956No subdomain70–7
Wright38 2005SDI-21 providing for the family domainUKEnglishDevelopment and validation studyAge: 53.8±14.1 years
Male: Not specific
Cancer type: brain, lung cancers and others		271One domain regarding providing for the family50–20
Wright16 2011SDI-16 money matters domainUKEnglishDevelopment and validation studyAge: 56 (18-88) yrs for men; 56 (21-88) yrs for women
Male: 48%
Cancer type: breast, gastrointestinal, haematology, gynaecological, germ cell, head and neck, lung, genitourinary and others		652One domain regarding money matters50–20
Yu39 2021COST-v1, Simplified Chinese versionMainland ChinaChineseValidation studyAge: 57.0±9.2 years
Male: 45.7%
Cancer type: lung, stomach, colorectal and breast cancer		440No subdomain110–44
Zebrack40 2010IOC-CS financial problems domainUSAEnglishValidation studyAge: 26.7±5.3 years
Male: 48.0%
Cancer type: haematological, brain and solid tumours/soft tissue tumours		519One domain regarding financial problems31–15
Zhao41 2009CPILS employment/financial domainUSAEnglishValidation studyAge: ≤55 years 48.8%; >55 510.2%
Male: 41.6%
Cancer type: breast, prostate, colorectal, bladder, uterine, kidney, lung and ovarian cancer; melanoma of skin; non-Hodgkin's lymphoma,		5901One domain regarding employment/finances60–12

  • AJCC, The American Joint Committee on Cancer; CCEQ, Chronic Cancer Experiences Questionnaire; COST, Comprehensive Score for Financial Toxicity; CPILS, Cancer Problems in Living Scale; FIT, Financial Index of Toxicity; IOC-CS, Impact of Cancer-Childhood Survivors; NR, not report; PFB, Personal Financial Burden; PROFFIT, Patient-Reported Outcome for Fighting Financial Toxicity; PROM, Patient-Reported Outcome Measures; PRRS, Patient Roles and Responsibilities Scale; P-SAFE, Patient Self-Administered Financial Effects questionnaire; QLACS, Quality of Life in Adult Cancer Survivors; SDI, Social Difficulties Inventory Cancer Care Outcomes; SFDQ, Subjective Financial Distress Questionnaire; SWBS, Socioeconomic Well-being Scale.